Korea

/DISREGARD RELEASE: SK networks/

We are advised by SK networks that journalists and other readers should disregard the news release, SK Networks invests$22M in the U.S. AI device startup 'Humane', issued10-Mar-2023 over PR Newswire. ...

2023-03-10 21:32 5234

SK Inc. materials increases its US investments to expand the CCUS business

* Affiliates of SK Inc. materials plan to increase investments in 8 Rivers to strengthen the partnership * 8 Rivers is an innovative clean energy technology company with supercritical CO2 power generation and blue hydrogen production technologies * SK Inc. materials plans to pursue high-grow...

2023-03-10 10:11 2618

Hugel Nominates Suk-yong Cha as Non-Executive Director

* Hugel's 22nd General shareholders' meeting to take place on March 30th * Proposed appointment of Suk-yong Cha as new non-executive director as an agenda item SEOUL, South Korea, March 9, 2023 /PRNewswire/ -- Hugel, a global total medical aesthetic company, announced onMarch 9th that it wil...

2023-03-09 23:00 3152

Siita, the world's first zero-waste company

NEW YORK, March 9, 2023 /PRNewswire/ -- Following announcement covered by Korea Herald, South Korean vegan cosmetics brand Siita said Thursday (Mar 2nd) that it has been recognized as one of the first zero waste companies globally by a sustainable fashion and lifestyle platform affiliated with th...

2023-03-09 21:00 2285

Hyundai Mobis pushes the boundaries of safety innovations with breakthrough airbag technology

* Brain Injury Prevention Airbag gets a perfect score from the US' Obilique crash test and wins the Silver Tower Order of Industrial Service Merit in the government-held New Technology Commercialization Competition. * The company unveiled various innovations including Face-to-face Protection ...

2023-03-09 21:00 3346

BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events

CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ -- BIORCHESTRA , a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS) by leveraging its proprietary Brain-Targeting RNAi Nanomedi...

2023-03-08 22:47 2580

Wonderers, A New Action-Adventure Game To Start Closed Beta Test Soon

* A multi-genre action-adventure game including roguelike and MOBA, social features, and more * Create your own story in a fairy tale realm brought to life by adorable characters and sophisticated graphics SEOUL, South Korea, March 7, 2023 /PRNewswire/ -- Wonderers: Eternal World, a new actio...

2023-03-08 01:00 3005

Hyundai Mobis Introduces Electronic Leveling Control for EVs and PBVs

* ELC co-developed with Hyundai Motor Company to protect EV batteries, increase driving range, and make it easier to get on and off vehicles. * The system adjusts the height by up to 6 cm in various circumstances, including rough roads, highways, and parking lots. * Provides features seen in...

2023-03-06 21:00 2832

HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis

* The trial met its primary endpoint and key secondary endpoints, with a favorable safety profile * Batoclimab is one of the most advanced FcRn inhibitors being developed in Greater China for the treatment of myasthenia gravis SEOUL, South Korea, March 6, 2023 /PRNewswire/ -- HanAll Biopharma...

2023-03-06 20:00 2521

SurplusGLOBAL Announces Executive Promotion, Recruitment, and Establishment of Equipment Technology Team

SEOUL, South Korea, March 3, 2023 /PRNewswire/ -- SurplusGLOBAL, the leading global platform company for pre-owned semiconductor equipment ( www.SurplusGLOBAL.com ), announced on the 27th a major organizational restructuring to achieve sustainable business growth u...

2023-03-03 22:00 4950

Neurophet to unveil new technology for analyzing ARIA side effect at ECR 2023

* Introducing brain imaging analysis solutions including Neurophet AQUA and Neurophet SCALE PET * Unveiling technology to analyze and monitor ARIA, side effect of anti-amyloid antibody drug for Alzheimer's disease SEOUL, South Korea, March 2, 2023 /PRNewswire/ -- Neurophet, an artificial inte...

2023-03-02 22:00 3039

ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA

* ExoGMP™ is the world's largest exosome manufacturing facility in Osong, South Korea. * Cellosome™ HA fillers are expected to be approved in 2023. * ExoCoBio has all 3 types of GMP clearance for pharmaceuticals, medical devices, & cosmetics. SEOUL, South Korea, March 2, 2023 /PRNewswire/ -...

2023-03-02 14:09 7429

GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology

* Entered into an acquisition deal of 3 programs YONGIN, South Korea, Feb. 27, 2023 /PRNewswire/ -- GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that it has signed an Asset Purchase Agreement with Catalyst Biosciences (NASDAQ : ...

2023-02-28 08:53 2963

LG Innotek to lead the future device market with high-performance 2-Metal COF

* Supporting high-resolution display... Expected to increase the level of immersion for users.  * Flexibility and unbounded design with thin films * Creating differentiated customer values with 2-Metal Chip on Film (COF) highlighting 50 years of substrate business SEOUL, South Korea, Feb. 27...

2023-02-27 22:00 2645

Oysterable Showcases AIoT Smart Resource Circulation Solution 'Lalaloop' at MWC2023

* Lalaloop© AIoT resource circulation solution enables lifecycle data management of resources from manufacturing to reprocessing via LalaloopID© and AIoT self-serve Reverse Vending Machine (RVM). * It tracks individual and corporate carbon emissions and has been recognized as the smartest sol...

2023-02-27 17:00 3842

PiQuant Wins CES 2023 Innovation Award for Spectroscopy-based Detection Tool

SEOUL, South Korea, Feb. 26, 2023 /PRNewswire/ -- PiQuant- Co., Ltd. (CEO: Doyeon Pi), a spectroscopy-based environmental IoT company, has won the CES 2023 Innovation Award from the Consumer Technology Association (CTA) of America. CES...

2023-02-27 10:00 3787

Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib

* With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving the door open for partnership PANGYO, South Korea, Feb. 24, 2023 /PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of cevidop...

2023-02-24 22:00 4417

Rayence unveils the first X-ray detector technology utilizing SPAD technology

* Presenting the cutting-edge detector technology, 'SPAD-GS', which is 2.5 times more sensitive to X-rays and 4 times faster than ever * Implemented the world's first X-ray detector using the 'SPAD', digital pixel technology capable of single-photon detection * Being announced and drawing at...

2023-02-23 21:00 3585

Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration

* Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea®  Biosimilar (ALT-L9) clinical development and licensing-out discussions. * Early 2024 projected for Phase 3 completion and product launch in Europe expected after obtaining approval in the first half of 2025. DAEJEON, So...

2023-02-22 22:00 3488

MAXST will Showcase Metaverse Service Development Platform at MWC 2023

SEOUL, South Korea and BARCELONA, Spain, Feb. 22, 2023 /PRNewswire/ -- MAXST Co., Ltd., a company specializing in the metaverse platform, will participate in MWC 2023 (Mobile World Congress 2023), held inBarcelona, Spain from February 27 to March 2.

2023-02-22 22:00 3468
1 ... 9899100101102103104 ... 141